CX Institutional’s Innospec IOSP Stock Holding History

CX Institutional’s Portfolio IOSP Stock Details IOSP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-133	Closed	-$13K	–	795
2022 Q2	$13K	Buy	+133	New	+$12.9K	﹤0.01%	912

Other funds holding IOSP

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $3.89B AUM 16.15% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

CX Institutional's IOSP Position: Q3 2022 in Review

CX Institutional sold out of Innospec (IOSP) in Q3 2022, closing a stake of 133 shares — an estimated $13K sold.

CX Institutional first reported a position in IOSP in Q2 2022 and held it in 1 quarter. The position peaked at $13K in Q2 2022. 193 funds tracked by Wall St. Rank hold IOSP as of Q3 2022.

CX Institutional reported no remaining Innospec position as of Q3 2022 after selling out during the quarter.
CX Institutional sold 133 Innospec shares in Q3 2022, an estimated $13K.
CX Institutional first reported a position in Innospec in Q2 2022 and held it in 1 quarter.
CX Institutional's Innospec position peaked at $13K in Q2 2022.
193 funds tracked by Wall St. Rank held Innospec as of Q3 2022.

Based on CX Institutional's 13F filing for Q3 2022, filed 4 Nov 2022.